These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39050847)

  • 1. Establishment and characterization of an h
    Liu H; Brostoff T; Ramirez A; Wong T; Rowland DJ; Heffner M; Flores A; Willis B; Evans JJ; Lanoue L; Lloyd KCK; Coffey LL
    Front Immunol; 2024; 15():1428711. PubMed ID: 39050847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
    Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
    Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
    Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
    mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection.
    Song IW; Washington M; Leynes C; Hsu J; Rayavara K; Bae Y; Haelterman N; Chen Y; Jiang MM; Drelich A; Tat V; Lanza DG; Lorenzo I; Heaney JD; Tseng CK; Lee B; Marom R
    Mamm Genome; 2024 Jun; 35(2):113-121. PubMed ID: 38488938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    Golden JW; Zeng X; Cline CR; Garrison AR; White LE; Fitzpatrick CJ; Kwilas SA; Bowling PA; Fiallos JO; Moore JL; Sifford WB; Ricks KM; Mucker EM; Smith JM; Hooper JW
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33961540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
    Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
    Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
    Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
    PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Outcomes of Infection by Wild-Type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 Variants of Concern in K18-hACE2 Transgenic Mice.
    He Y; Henley J; Sell P; Comai L
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice.
    Amruta N; Engler-Chiurazzi EB; Murray-Brown IC; Gressett TE; Biose IJ; Chastain WH; Befeler JB; Bix G
    Life Sci; 2021 Nov; 284():119881. PubMed ID: 34389403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion.
    Fumagalli V; Ravà M; Marotta D; Di Lucia P; Laura C; Sala E; Grillo M; Bono E; Giustini L; Perucchini C; Mainetti M; Sessa A; Garcia-Manteiga JM; Donnici L; Manganaro L; Delbue S; Broccoli V; De Francesco R; D'Adamo P; Kuka M; Guidotti LG; Iannacone M
    Sci Immunol; 2022 Jan; 7(67):eabl9929. PubMed ID: 34812647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains.
    Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H
    Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
    Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
    Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.